CoChat

miR-146a Controls Immune Response in the Melanoma Microenvironment

Open access
Mastroianni, Justin, Stickel, Natalie, Andrlova, Hana, Hanke, Kathrin, Melchinger, Wolfgang, Duquesne, Sandra, Schmidt, Dominik, Falk, Martina, Andrieux, Geoffroy, Pfeifer, Dietmar, Dierbach, Heide, Schmitt-Graeff, Annette, Meiss, Frank, Boerries, Melanie, Zeiser, Robert · 2019 · Cancer Research
Cited by 102

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

MicroRNAs (miR) are small noncoding RNAs that regulate gene expression, posttranscription, and manipulate immune responses in different types of cancers. In this study, we identify miR-146a as a negative regulator of immune activation, comparable to immune-checkpoint molecules. miR-146a levels were increased in melanoma microenvironmental tissue, and miR-146a−/− mice survived longer and developed less metastases in comparison with wild-type melanoma-bearing mice. T cells isolated from miR-146a−/− mice revealed higher expression levels of the miR-146a target gene Stat1 and the Stat1-regulated cytokine IFNγ. Neutralization of IFNγ in miR-146a−/− mice decreased survival and increased melanoma metastasis patterns to those of wild-type mice. In vitro, IFNγ reduced melanoma cell migration, cell-cycle activity, and basal metabolic rate. Conversely, IFNγ also increased PD-L1 levels on the melanoma cells, which may counterbalance some of the beneficial effects increasing immune escape in vivo. Combined treatment with a miR-146a antagomiR and anti–PD-1 resulted in improved survival over isotype control or anti–PD-1 treatment alone. In summary, these data show that miR-146a plays a central role within the STAT1/IFNγ axis in the melanoma microenvironment, affecting melanoma migration, proliferation, and mitochondrial fitness as well as PD-L1 levels. Additionally, combined inhibition of PD-1 and miR-146a could be a novel strategy to enhance antitumor immune response elicited by checkpoint therapy. Significance: These findings identify a microRNA–based mechanism by which melanoma cells escape the immune system, providing a new therapeutic strategy to improve the current management of patients with melanoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-18-1397

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 102

Metadata

Authors
Mastroianni, J., Stickel, N., Andrlova, H., Hanke, K., Melchinger, W., Duquesne, S., Schmidt, D., Falk, M., Andrieux, G., Pfeifer, D., Dierbach, H., Schmitt-Graeff, A., Meiss, F., Boerries, M., & Zeiser, R.
Venue
Cancer Research
Published
2019-01-01
Volume
79
Issue
1
Pages
183-195
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2900587291
Cited by
102
References
2
FWCI
4.13
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: miR-146a Controls Immune Response in the Melanoma Microenvironment. https://app.cochat.ai/papers/10.1158/0008-5472.can-18-1397
The paper
Mastroianni, J., Stickel, N., Andrlova, H., Hanke, K., Melchinger, W., Duquesne, S., Schmidt, D., Falk, M., Andrieux, G., Pfeifer, D., Dierbach, H., Schmitt-Graeff, A., Meiss, F., Boerries, M., & Zeiser, R. (2019). miR-146a Controls Immune Response in the Melanoma Microenvironment. Cancer Research. https://doi.org/10.1158/0008-5472.can-18-1397

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.